4.5 Article

Multidrug-resistant Pseudomonas aeruginosa infections pose growing threat to health care-associated infection control in the hospitals of Southern China: A case-control surveillance study

Journal

AMERICAN JOURNAL OF INFECTION CONTROL
Volume 42, Issue 12, Pages 1308-1311

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.ajic.2014.08.006

Keywords

Multidrug-resistant Pseudomonas aeruginosa; Southern China; Case-control surveillance

Funding

  1. Guangdong Science and Technology Planning Project [2008B030301034]

Ask authors/readers for more resources

Background: Multidrug-resistant Pseudomonas aeruginosa (MDRPA) is one of the most common agents among health careeassociated infections. There is a lack of data on the clinical features of MDRPA from Southern China. Methods: A case-control surveillance study of P aeruginosa was conducted based on surveillance from July 2008-December 2012, in 5 hospitals of Guangzhou, China. Data were analyzed by univariate analysis and multivariate logistic regression using Stata 13 (StataCorp, College Station, TX). Results: Of the 348 P aeruginosa strains, the prevalence of MDRPA was 54%, and it has increased over time. Isolates of P aeruginosa showed increased resistance to most antimicrobials during this time period. Independent risk factors were tracheal intubation insertion (odds ratio [OR], 2.21; 95% confidence interval [CI], 1.16-4.23; P < .02) and use of carbapenem (odds ratio [OR], 3.36; 95% confidence interval [CI], 1.75-6.47; P < .01). The distribution of MDRPA infections was uneven among the 5 hospitals (P = .01). Being infected with MDRPA strains resulted in longer duration of hospitalization (39 vs 24 days) and higher mortality (49% vs 20%). Conclusion: The infections of MDRPA were severe issues. More stringent measures should be applied for those with independent predictors of MDRPA infections because they may induce adverse clinical outcomes. Copyright (C) 2014 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available